An FDA pilot program highlighted a continuing dilemma that threatens to soil the reputation of law-abiding dietary supplement companies in the United States: the presence of undeclared drugs in products coming from overseas. Michael McGuffin of the American Herbal Products Association stressed FDA should differentiate between lawful dietary supplements and ones that purport to be supplements but are, in fact, unapproved drugs.
April 12, 2018
10 Min Read